116 related articles for article (PubMed ID: 34821436)
1. A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system.
Wu J; Wang P; Han Z; Li T; Yi C; Qiu C; Yang Q; Sun G; Dai L; Shi J; Wang K; Ye H
Cancer Sci; 2022 Feb; 113(2):411-422. PubMed ID: 34821436
[TBL] [Abstract][Full Text] [Related]
2. Combination of an Autoantibody Panel and Alpha-Fetoprotein for Early Detection of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Shen Y; Chen J; Wu J; Li T; Yi C; Wang K; Wang P; Sun C; Ye H
Cancer Prev Res (Phila); 2024 May; 17(5):227-235. PubMed ID: 38489403
[TBL] [Abstract][Full Text] [Related]
3. Development of a machine learning-based model to predict prognosis of alpha-fetoprotein-positive hepatocellular carcinoma.
Dong B; Zhang H; Duan Y; Yao S; Chen Y; Zhang C
J Transl Med; 2024 May; 22(1):455. PubMed ID: 38741163
[TBL] [Abstract][Full Text] [Related]
4. Establishment and Validation of a Blood Test-based Nomogram to Diagnose Patients with AFP-negative HCC.
Wu Y; Liu S; Fan Z; Tian Y; Zhang L; Liu S
Curr Cancer Drug Targets; 2024; 24(5):556-564. PubMed ID: 38178672
[TBL] [Abstract][Full Text] [Related]
5. A panel of autoantibodies against multiple tumor-associated antigens in the immunodiagnosis of esophageal squamous cell cancer.
Zhang HF; Qin JJ; Ren PF; Shi JX; Xia JF; Ye H; Wang P; Song CH; Wang KJ; Zhang JY
Cancer Immunol Immunother; 2016 Oct; 65(10):1233-42. PubMed ID: 27553002
[TBL] [Abstract][Full Text] [Related]
6. Proteome microarray identifies autoantibody biomarkers for diagnosis of hepatitis B-related hepatocellular carcinoma.
Zhang J; Hao W; Liu X; Meng Y; Liu J; Wu L; Zhang Y; Hu X; Fan Y; Qin X
Clin Chim Acta; 2024 Feb; 554():117727. PubMed ID: 38123112
[TBL] [Abstract][Full Text] [Related]
7. Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma.
Son JA; Weon JH; Baek GO; Ahn HR; Choi JY; Yoon MG; Cho HJ; Cheong JY; Eun JW; Kim SS
J Exp Clin Cancer Res; 2023 Oct; 42(1):288. PubMed ID: 37899451
[TBL] [Abstract][Full Text] [Related]
8. Plasma methylated GNB4 and Riplet as a novel dual-marker panel for the detection of hepatocellular carcinoma.
Zhao Y; Zhao L; Jin H; Xie Y; Chen L; Zhang W; Dong L; Zhang L; Huang Y; Wan K; Yang Q; Wang S
Epigenetics; 2024 Dec; 19(1):2299044. PubMed ID: 38154055
[TBL] [Abstract][Full Text] [Related]
9. Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer.
Cheng Y; Li Q; Sun G; Li T; Zou Y; Ye H; Wang K; Shi J; Wang P
Sci Rep; 2024 Apr; 14(1):9757. PubMed ID: 38684875
[TBL] [Abstract][Full Text] [Related]
10. Proteomics-driven noninvasive screening of circulating serum protein panels for the early diagnosis of hepatocellular carcinoma.
Xing X; Cai L; Ouyang J; Wang F; Li Z; Liu M; Wang Y; Zhou Y; Hu E; Huang C; Wu L; Liu J; Liu X
Nat Commun; 2023 Dec; 14(1):8392. PubMed ID: 38110372
[TBL] [Abstract][Full Text] [Related]
11. A new biomarker panel for differential diagnosis of cholangiocarcinoma: Results from an exploratory analysis.
Köhler B; Bes M; Chan HL; Esteban JI; Piratvisuth T; Sukeepaisarnjaroen W; Tanwandee T; Thongsawat S; Mang A; Morgenstern D; Swiatek-de Lange M; Dayyani F
Int J Biol Markers; 2024 Jun; 39(2):107-117. PubMed ID: 38549363
[TBL] [Abstract][Full Text] [Related]
12. HCC-Check: A Novel Diagnostic Tool for Early Detection of Hepatocellular Carcinoma Based on Cytokeratin-1 and Epithelial Membrane Antigen: A Cross-Sectional Study.
Attallah KA; Albannan MS; Farid K; Rizk SM; Fathy N
Technol Cancer Res Treat; 2024; 23():15330338241234790. PubMed ID: 38436112
[No Abstract] [Full Text] [Related]
13. Development and Evaluation of Novel Statistical Methods in Urine Biomarker-Based Hepatocellular Carcinoma Screening.
Wang J; Jain S; Chen D; Song W; Hu CT; Su YH
Sci Rep; 2018 Feb; 8(1):3799. PubMed ID: 29491388
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel tumor-associated antigens and evaluation of a panel of autoantibodies in detecting oral cancer.
Xie W; Sun G; Xia J; Chen H; Wang C; Lin J; Wang P
BMC Cancer; 2023 Aug; 23(1):802. PubMed ID: 37641028
[TBL] [Abstract][Full Text] [Related]
15. Circulating mortalin autoantibody--a new serological marker of liver cirrhosis.
Lu WJ; Saxena N; Luk JM; Kaul SC; Wadhwa R
Cell Stress Chaperones; 2015 Jul; 20(4):715-9. PubMed ID: 25905813
[TBL] [Abstract][Full Text] [Related]
16. Identification of Novel Autoantibodies Based on the Human Proteomic Chips and Evaluation of Their Performance in the Detection of Gastric Cancer.
Cui C; Duan Y; Qiu C; Wang P; Sun G; Ye H; Dai L; Han Z; Song C; Wang K; Shi J; Zhang J
Front Oncol; 2021; 11():637871. PubMed ID: 33718231
[TBL] [Abstract][Full Text] [Related]
17. Advanced Nanoencapsulation-Enabled Ultrasensitive Analysis: Unraveling Tumor Extracellular Vesicle Subpopulations for Differential Diagnosis of Hepatocellular Carcinoma via DNA Cascade Reactions.
Li X; Liu Y; Fan Y; Tian G; Shen B; Zhang S; Fu X; He W; Tao X; Ding X; Li X; Ding S
ACS Nano; 2024 Apr; 18(17):11389-11403. PubMed ID: 38628141
[TBL] [Abstract][Full Text] [Related]
18. Detection of autoantibodies to multiple tumor-associated antigens in the immunodiagnosis of ovarian cancer.
Li L; Wang K; Dai L; Wang P; Peng XX; Zhang JY
Mol Med Rep; 2008; 1(4):589-94. PubMed ID: 20523766
[TBL] [Abstract][Full Text] [Related]
19. Development of machine learning-based predictors for early diagnosis of hepatocellular carcinoma.
Zhang ZM; Huang Y; Liu G; Yu W; Xie Q; Chen Z; Huang G; Wei J; Zhang H; Chen D; Du H
Sci Rep; 2024 Mar; 14(1):5274. PubMed ID: 38438393
[TBL] [Abstract][Full Text] [Related]
20. hccTAAb Atlas: An Integrated Knowledge Database for Tumor-Associated Autoantibodies in Hepatocellular Carcinoma.
Li T; Wang P; Sun G; Zou Y; Cheng Y; Wang H; Lu Y; Shi J; Wang K; Zhang Q; Ye H
J Proteome Res; 2024 Feb; 23(2):728-737. PubMed ID: 38156953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
